Indiana hospitals pull merger application after pushback over monopoly concerns

Two rival hospitals in Terre Haute, Indiana, pulled back their merger application Monday, just days before the state was due to rule on the deal amid growing backlash to such medical monopolies.

J&J makes small I&I acquisition to enter competitive IL-13, TSLP arena

Johnson & Johnson said Thursday it will pay $850 million in cash for Proteologix, a relatively unknown private biotech working on treatments for immune-mediated diseases,

May 17, 2024

Study uncovers thousands of medication pairings linked to frequent dosage adjustments

Researchers investigated the complexity of polypharmacy and whether frequent dose adjustments were required for co-medications and drug pairs in hospital settings.

September 7, 2023

Biogen ends agreement with Acorda for multiple sclerosis drug Fampyra

Biogen is handing back ex-US commercialization rights to Acorda Therapeutics for the multiple sclerosis drug Fampyra. Acorda will have the drug in-house effective Jan. 1,

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.